Belgium

Luxembourg

Netherlands

Protease / phosphatase inhibitor cocktails

Inhibitors / activators

We offer a wide range of chemicals that includes biochemicals, click chemistry products, inhibitors, small molecules, amino acid derivatives, antibiotics, (blocking) buffers, adjuvant, solvents and diluents as well as stains, labels and dyes.<br><br>You will find many categories within the assay product group, so you can select one to find the product you need quickly. Click on one of the categories for an overview of our products.

Bio-Connect offers a wide range of chemicals that includes biochemicals, click chemistry products, inhibitors, small molecules and many more.

Chemicals

Bio-Connect supplier for all your research chemicals

AdipoGen Life Sciences

Supplier

Research Use Only

Certification

606143-52-6

CAS number

Bio-Connect Life Sciences

Business unit

AG-CR1-3757 | Selumetinib [606143-52-6] | AdipoGen Life Sciences products available at Bio-Connect

Selumetinib [606143-52-6]... | AG-CR1-3757 | AdipoGen Life Sciences

Selumetinib [606143-52-6]

Chemical. CAS: 606143-52-6. Formula: C17H15BrClFN4O3. MW: 457.7. Selumetinib is an orally available, potent and selective ATP non-competitive inhibitor of the mitogen-activated protein kinases MEK1 (IC50 = 14 nM) and MEK2 (Kd = 530 nM). MEK1 and MEK2 specifically act downstream of growth factor receptors and the proto-oncogenes Ras and Raf to activate ERK1 and ERK2, often leading to an increase in cell proliferation. It inhibits ERK1/2 phosphorylation (IC50 = 10 nM), but exhibits only weak activity at p38alpha, MKK6, EGFR, ErbB2 and ERK2. Selumetinib inhibits growth of several tumor cell lines but not normal fibroblast lines and shows potent dose-dependent antitumor activity against a panel of mouse xenograft models of colorectal, pancreatic, liver, skin and lung cancer. It inhibits proliferation and induces differentiation and apoptosis in multiple tumor cell lines and tumor xenograft models, and inhibits proliferation of breast cancer and non-small cell lung cancer cell lines, especially those containing Raf and Ras mutations, respectively. - Selumetinib is an orally available, potent and selective ATP non-competitive inhibitor of the mitogen-activated protein kinases MEK1 (IC50 = 14 nM) and MEK2 (Kd = 530 nM). MEK1 and MEK2 specifically act downstream of growth factor receptors and the proto-oncogenes Ras and Raf to activate ERK1 and ERK2, often leading to an increase in cell proliferation. It inhibits ERK1/2 phosphorylation (IC50 = 10 nM), but exhibits only weak activity at p38alpha, MKK6, EGFR, ErbB2 and ERK2. Selumetinib inhibits growth of several tumor cell lines but not normal fibroblast lines and shows potent dose-dependent antitumor activity against a panel of mouse xenograft models of colorectal, pancreatic, liver, skin and lung cancer. It inhibits proliferation and induces differentiation and apoptosis in multiple tumor cell lines and tumor xenograft models, and inhibits proliferation of breast cancer and non-small cell lung cancer cell lines, especially those containing Raf and Ras mutations, respectively.

Website

Tech support

Our company

Our team

Divisions

Vacatures

Events

Promotions

About us

Contact

Our people

Antibodies

Proteins / Signaling Molecules

Assays

(Cell) Culture

Products

Our Company

Suppliers

News

Bio-Connect

Biotech, Pharma & CRO

Academia

Diagnostics

Environment

Food

Veterinary

Industries

Disclaimer

Privacy Statement

Terms and conditions

Are you looking for specific products, alternatives, documentation or need assistance with solving product related issues? Let our in-house technical support team help you.

We support your research

<p>For 15 years, we connect life science researchers specialized in the import and distribution of life science reagents from global suppliers.</p>

Support your research

DNA / RNA / Vectors

Cell Culture

Genome Editing and Engineering

Molecular Biology

Lysates / Extracts

Expression

Labware / Accesories

Body Products

Technique Specific Products

Arrays / Slides

Call +31 (0)26 326 44 50

Inhibitors / activators

Didn't find what you were looking for?